Published on 6 Mar 2024 on Simply Wall St. via Yahoo Finance
Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
Key Insights
Significantly high institutional ownership implies Rigel Pharmaceuticals' stock price is sensitive to their trading actionsThe top 13 shareholders own 50% of the company Insiders have sold recently
If you want to know who really controls Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), then you'll have to look at the makeup of its share registry. With 47% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).